To address this challenge, CTMC has established a patient material bank, enabling early-stage process development with clinically relevant samples. This resource also supports continuous process ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss t ...

Novita Pharmaceuticals, Inc. ("Novita"), a privately held, clinical-stage pharmaceutical company dedicated to developing novel cancer drugs through its proprietary fascin inhibitor technology, today ...

Zymeworks Inc. , a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, ...

One reason is the fact that much research related to ovarian cancer has focused on strategies ... urgent need to improve strategies to prolong survival, especially for all patients in a first ...

MSD has reported that the randomised Phase III KEYNOTE-B96 trial of Keytruda (pembrolizumab) plus chemotherapy (paclitaxel), ...

AZ will present new data on Merck & Co/MSD-partnered PARP drug Lynparza (olaparib) in ovarian, prostate and pancreatic cancer ... in progression-free survival (PFS) as a first-line maintenance ...

Bayer BAYRY announced first-quarter 2025 results. Novo Nordisk NVO and GSK plc GSK announced licensing deals with smaller ...

Discussing ‘cure’ may risk oncologists’ credibility, should a patient’s ovarian cancer recur,” researchers wrote.

CK Wang, MD, chief medical officer of COTA, highlights how a lack of screening tools and declining ob-gyn pipeline can ...

BcRAVE (Breast Cancer Risk Assessment through Uncertain Variant Classification Empowerment) with €129,000 in funding, is part of the “Horizon Europe – 2nd Chance – MSCA” scheme and ...

Oktay doesn’t know yet if this procedure will delay or even stop menopause—it’s still in experimental phases. So far, his clinical trial has only collected ovarian tissue. It will take anoth ...